This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.83% per year. These returns cover a period from January 1, 1988 through January 5, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
aerospace: Archive
General Dynamics to Post Q4 Earnings: Here's What to Expect
by Zacks Equity Research
GD heads into Q4 earnings with higher Gulfstream deliveries, submarine work and solid demand. However, supply-chain issues may have weighed on profits.
GDNegative Net Change CAENegative Net Change WWDNegative Net Change DPRONegative Net Change
aerospace
BAE Systems Wins $473M Deal to Produce 40 M109A7 Paladin Howitzer
by Zacks Equity Research
BAESY secures a $473M contract to build 40 M109A7 Paladin howitzer sets, strengthening the U.S. Army's firepower and its armored vehicle footprint.
GDNegative Net Change TXTNegative Net Change BAESYNegative Net Change RTXNegative Net Change
aerospace
Take the Zacks Approach to Beat the Markets: Drilling Tools, Alcoa & Starbucks in Focus
by Santanu Roy
Starbucks delivered 15.6% gains in 12 weeks as Zacks portfolios highlighted standout stock winners amid volatile markets.
JNJPositive Net Change WMTNegative Net Change AANegative Net Change SBUXPositive Net Change CLNegative Net Change TDCPositive Net Change ULTANegative Net Change HIIPositive Net Change MPWRPositive Net Change NOBLNegative Net Change OOMANegative Net Change DTINegative Net Change
aerospace communications computers consumer-staples industrial-products oil-energy pharmaceuticals restaurants retail semiconductor
Defense ETFs to Watch Before Q4 Earnings Season Unfolds
by Aparajita Dutta
SHLD and other defense ETFs are in focus as Q4 earnings loom, with rising global military spending set to validate record contract-driven growth.
BAPositive Net Change LMTPositive Net Change GENegative Net Change GDNegative Net Change SHLDNegative Net Change KTOSNegative Net Change ITANegative Net Change PPANegative Net Change XARNegative Net Change LHXNegative Net Change RTXNegative Net Change RKLBPositive Net Change KRMNPositive Net Change
aerospace etfs
Here's Why You Should Add LUNR Stock to Your Portfolio Right Now
by Zacks Equity Research
Intuitive Machines' strong liquidity, rising sales estimates and lunar infrastructure expansion drive a 60.8% rally, highlighting its growth case in aerospace.
HIIPositive Net Change DPRONegative Net Change RDWNegative Net Change LUNRPositive Net Change
aerospace
Leidos Partners With OpenAI to Deploy AI Solutions Across Sectors
by Zacks Equity Research
LDOS teams up with OpenAI to embed generative and agentic AI into mission-critical government workflows across defense, health and infrastructure.
LMTPositive Net Change NOCPositive Net Change LDOSNegative Net Change RTXNegative Net Change
aerospace
3 Stocks Positioned to Gain From Renewed U.S. Defense Priorities
by Abhinab Dasgupta
Defense stocks are rallying as U.S. defense priorities sharpen, putting KTOS, HII and TDY in focus amid expectations for higher spending and modernization.
HIIPositive Net Change TDYNegative Net Change KTOSNegative Net Change
aerospace
Can Qorvo's Rising Revenues Rescue the Stock in Q3 Earnings?
by Zacks Equity Research
QRVO is set to report Q3 fiscal 2026 on Jan. 27 amid rising revenues, Apple R&D costs, and merger-related integration risks.
AMDNo Net Change SWKSNegative Net Change CRUSPositive Net Change GOOGLNegative Net Change QRVONegative Net Change
aerospace communications mobile semiconductor tech-stocks
GE Aerospace Q4 Earnings & Revenues Top Estimates, Increase Y/Y
by Zacks Equity Research
GE tops Q4 estimates as strong engine services demand lifted revenues 18% year over year, with orders surging and 2026 growth outlook raised.
GENegative Net Change HIIPositive Net Change KTOSNegative Net Change GEVPositive Net Change
aerospace earnings
Jobless Claims Stay Low at +200K, Q3 GDP Up to +4.4%
by Mark Vickery
Weekly Jobless Claims continue to portray a labor market cruising along at a healthy low rate of unemployment claims.
GENegative Net Change INTCPositive Net Change ABTNegative Net Change FCXPositive Net Change PGNegative Net Change COFPositive Net Change ISRGNegative Net Change
aerospace basic-materials earnings pharmaceuticals staffing